Plant-Based Anticancer Compounds With a Focus on Breast Cancer

Area of Science:

• Oncology
• Pharmacognosy
• Natural Product Chemistry

Background:

• Breast cancer is a prevalent malignancy in women, with conventional treatments like chemotherapy and radiation therapy posing significant adverse events and financial burdens, especially in developing nations.
• The limitations of current therapies necessitate the exploration of alternative treatments that are both effective and economically viable.
• Plants represent a rich source of novel compounds with potential anticancer properties, offering a promising avenue for therapeutic development.

Purpose of the Study:

• To provide a comprehensive overview of known anticancer compounds derived from plants.
• To detail the sources and molecular mechanisms of action of these plant-derived anticancer agents.
• To discuss the opportunities and challenges associated with developing plant-based anticancer therapies for clinical application.

Main Methods:

• Literature review of existing research on plant-derived anticancer compounds.
• Analysis of molecular mechanisms underlying the efficacy of these compounds.
• Evaluation of the potential and limitations for clinical translation of plant-based cancer treatments.

Main Results:

• Plant-derived compounds exhibit diverse pleiotropic effects and can selectively target cancer cells, sparing healthy ones.
• These natural products offer advantages such as reduced toxicity, cost-effectiveness, and improved safety profiles compared to conventional treatments.
• Despite their potential, challenges remain in optimizing bioactive compounds for clinical trials and drug development.

Conclusions:

• Plant-derived compounds are a vital resource for developing novel, safer, and more affordable breast cancer therapies.
• Further investigation into the sources, mechanisms, and optimization of these natural products is crucial for advancing plant-based oncology.
• Overcoming current challenges will pave the way for improved plant-based medications in breast cancer treatment.